Securities code: 300633 securities abbreviation: Sonoscape Medical Corp(300633) Announcement No.: 2021-068 Sonoscape Medical Corp(300633)
Announcement on passive dilution of shareholding ratio of controlling shareholders and persons acting in concert exceeding 1%
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
This change in the rights and interests of the controlling shareholders and those acting in concert belongs to the change of the company’s share capital, the shareholding ratio is passively diluted, does not involve the reduction of shareholders’ shares, will not lead to the change of the company’s control and will not have an impact on the company’s operation and governance structure.
According to the reply on approving Sonoscape Medical Corp(300633) to issue shares to specific objects for registration (zjxk [2021] No. 668) issued by China Securities Regulatory Commission, Sonoscape Medical Corp(300633) (hereinafter referred to as “the company”) issues 27851745 RMB common shares (A shares) to specific objects. After the issuance of shares to specific objects, the total share capital of the company increased from 401920000 shares to 429771745 shares, and the registered capital increased from 401920000.00 yuan to
429771745.00 yuan.
Under the condition that the number of shares held by the company’s controlling shareholders and their persons acting in concert has not changed, the company has issued shares to specific objects, resulting in the passive dilution of its shareholding ratio of more than 1%. The specific information is hereby announced as follows: I. Basic information of equity changes 1. Basic information
Information disclosure obligor 1 Chen Zhiqiang
Contact address: Room 201, building 12, phase II, science and technology software park, No. 1, kekekezhong 2 Road, Nanshan District, Shenzhen, Guangdong Province
Information disclosure obligor 2: Wu Kunxiang
Contact address: Room 201, building 12, phase II, science and technology software park, No. 1, kekekezhong 2 Road, Nanshan District, Shenzhen, Guangdong Province
Change time of Equity: January 6, 2022
Stock abbreviation Sonoscape Medical Corp(300633) stock code 300633
Change type
(more can be added □ less concerted action is available □
(optional)
Whether it is the largest shareholder or actual controller or not □
2. Changes in equity this time
Type of shares (A shares, B shares, etc.) number of shares increased / decreased (10000 shares) passive dilution ratio (%)
Chen Zhiqiang (a share) 01.55%
Wu Kunxiang (B shares) 01.55%
Total 03.09%
Centralized trading through stock exchange □ agreement transfer □
Block trading through stock exchange □ indirect transfer □
Method of this equity change (administrative transfer or change of multi-national shares □ execution of court ruling □
(optional) acquisition of new shares issued by listed companies □ succession □
Gift □ transfer of voting rights □
Others (passive reduction of shareholding ratio of information disclosure obligors due to the company’s issuance of shares to specific objects)
3. Before and after this change, investors and persons acting in concert owned shares of the interests of the listed company
Shares held before this change shares held after this change
Name of shareholder and nature of shares
Proportion of shares (shares) to total share capital proportion of shares (shares) to total share capital
Chen Zhiqiang restricted shares 9572520023.82% 9572520022.27%
Shares
Wu Kunxiang shares with unlimited sales conditions 9572520023.82% 9572520022.27%
Shares
Total 19145040047.63% 19145040044.55%
4. Performance of commitments, plans, etc
Whether this change is performed yes □ no
If yes, please explain the specific conditions and implementation progress of the commitment, intention and plan.
Is there any violation of the securities law and the purchase of Listed Companies in this change
Purchase management measures and other laws and regulations yes □ no
If yes, please specify the specific situation, rectification plan and treatment measures of the violation. 5. Shares with restricted voting rights
In accordance with Article 63 of the securities law yes □ no
If yes, please explain the proportion of the corresponding number of shares in the share capital of the existing listed company. Voting shares
6. Documents for future reference 1. Details of shareholding changes of China Securities Depository and Clearing Co., Ltd. □ 2. Relevant written commitment documents □ 3. Written opinions of lawyers □ 4. Other documents required by Shenzhen Stock Exchange note: if there is any difference in the mantissa between the sum of some totals and sub items in the above table, it is caused by rounding.
It is hereby announced.
Sonoscape Medical Corp(300633) board of directors December 31, 2021
